Overview

A Placebo Controlled Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women

Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
A placebo controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants
Phase:
Phase 2
Details
Lead Sponsor:
St George's, University of London
Collaborators:
MU-JHU CARE
Pfizer